Mizuho Begins Coverage on Medpace (NASDAQ:MEDP)

Analysts at Mizuho started coverage on shares of Medpace (NASDAQ:MEDP – Get Free Report) in a report issued on Tuesday, MarketBeat Ratings reports. The firm set a “buy” rating and a $435.00 price target on the stock. Mizuho’s price objective would suggest a potential upside of 12.12% from the company’s current price. Several other analysts […]

Related Keywords

United States ,America ,Ashleym Keating ,Susane Burwig ,Robertw Baird , ,Contravisory Investment Management Inc ,Mather Group ,Medpace Company Profile ,Jefferies Financial Group ,Riverpark Advisors ,Securities Exchange Commission ,Rise Advisors ,Deutsche Bank Aktiengesellschaft ,Medpace Holdings Inc ,Get Free Report ,Marketbeat Ratings ,Bank Aktiengesellschaft ,Trading Down ,Director Ashley ,Exchange Commission ,Park Advisors ,Investment Management ,North America ,Medpace Daily ,